U.S. Markets closed

Codexis, Inc. (CDXS)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.60+0.25 (+5.75%)
At close: 4:00PM EDT

4.60 0.00 (0.00%)
After hours: 4:00PM EDT

People also watch
AMRSCCXIGEVOCORTAVEO

Codexis, Inc.

200 Penobscot Drive
Redwood City, CA 94063
United States
650-421-8100
http://www.codexis.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees106

Key Executives

NameTitlePayExercisedAge
Mr. John J. NicolsChief Exec. Officer, Pres and Director1.12MN/A53
Mr. Gordon T. B. SangsterChief Financial Officer and Sr. VP591.21kN/A64
Mr. Michael D. A. Aldridge B.Sc (Hons)., MApFinSr. VP of Corp. & Strategic Devel.125.01kN/A50
Dr. James J. Lalonde Ph.D.Sr. VP of R&D480.54kN/A56
Mr. Keith McKayDirector of Bus. Devel.N/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Codexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company’s platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also improves the pharmaceuticals companies manufacturing productivity and efficiency, as well as helps in outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. Further, the company develops biocatalysts for use in the fine chemicals market, including food and food ingredients, animal feed, flavors and fragrances, and agricultural chemicals. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

Corporate Governance

Codexis, Inc.’s ISS Governance QualityScore as of May 1, 2017 is 8. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.